Lanean...
Therapeutic Potential of JAK2 Inhibitors for the Management of Myelofibrosis
Myelofibrosis (either primary or post-polycythemia vera/essential thrombocythemia) is a chronic and debilitating myeloproliferative neoplasm for which there is no well-accepted standard of care. Clinical manifestations of this disease (eg, cytopenias, splenomegaly, bone marrow fibrosis) and constitu...
Gorde:
| Argitaratua izan da: | Clin Cancer Res |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5017533/ https://ncbi.nlm.nih.gov/pubmed/20215535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2836 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|